SMYD5 and hepatocellular carcinoma: The results demonstrated that treatment of SMYD5 siRNA alone readily resulted in significantly suppressed HCC PDX growth, with an even greater effect achieved by combined treatment of Torin1 (Fig. 6d; Supplementary information, Fig. S7g).